Archives

by in
Entry Author Date Location
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego 06/03/13 San Diego
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More 10/05/12 San Diego
San Diego’s Regulus Lowers Share Price in Revised IPO Filing 10/04/12 San Diego
San Diego’s Regulus Therapeutics Readies for IPO This Week 10/01/12 San Diego
San Diego Life Sciences Roundup: Regulus IPO, Fate Funding, & More 08/23/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
IPOs, Biogen, Northeastern, & More From the Boston Life Sciences Roundup 08/17/12 Boston
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Biogen Idec, Regulus Cut Deal to Monitor Multiple Sclerosis 08/15/12 San Diego
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs 12/12/11 Seattle
The Fall of Pfizer: How Big is Too Big for Pharma Innovation? 08/29/11 National
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
Regulus Names Chief Scientist 04/18/11 San Diego
Regulus, UCSD Form Alliance 04/14/11 San Diego
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News 03/31/11 San Diego
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News 03/31/11 Seattle
Regulus Gets License From NYU 03/30/11 San Diego
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
John Mendlein Tries His Hand as a ‘Parallel Entrepreneur,’ Santaris Continues RNA Therapeutics Work for Pfizer, & More San Diego Life Sciences News 01/06/11 San Diego
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal with Glaxo 02/25/10 San Diego
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery 01/21/10 National
Ambit Signs Big Deal With Astellas, Xenomics Alleges Fraud at Sequenom, Arena Seeks FDA Approval for Weight-Loss Drug & More San Diego Life Sciences News 12/24/09 San Diego
Page 1 of 2 next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.